Abstract
Introduction: Systemic arterial hypertension (SAH) is a highly prevalent disease in the adult population. Functional cardiac impairments are frequent, and if not contained, they can result in heart failure and favoring a poor prognosis. The search for more efficient pharmacological therapy has been constant. In this regard, monotherapy with AT1 receptor blockers, such as valsartan, as wel…